Hsiao, Y.-T.; Shen, F.-C.; Weng, S.-W.; Wang, P.-W.; Chen, Y.-J.; Lee, J.-J.
Multiple Single Nucleotide Polymorphism Testing Improves the Prediction of Diabetic Retinopathy Risk with Type 2 Diabetes Mellitus. J. Pers. Med. 2021, 11, 689.
https://doi.org/10.3390/jpm11080689
AMA Style
Hsiao Y-T, Shen F-C, Weng S-W, Wang P-W, Chen Y-J, Lee J-J.
Multiple Single Nucleotide Polymorphism Testing Improves the Prediction of Diabetic Retinopathy Risk with Type 2 Diabetes Mellitus. Journal of Personalized Medicine. 2021; 11(8):689.
https://doi.org/10.3390/jpm11080689
Chicago/Turabian Style
Hsiao, Yu-Ting, Feng-Chih Shen, Shao-Wen Weng, Pei-Wen Wang, Yung-Jen Chen, and Jong-Jer Lee.
2021. "Multiple Single Nucleotide Polymorphism Testing Improves the Prediction of Diabetic Retinopathy Risk with Type 2 Diabetes Mellitus" Journal of Personalized Medicine 11, no. 8: 689.
https://doi.org/10.3390/jpm11080689
APA Style
Hsiao, Y.-T., Shen, F.-C., Weng, S.-W., Wang, P.-W., Chen, Y.-J., & Lee, J.-J.
(2021). Multiple Single Nucleotide Polymorphism Testing Improves the Prediction of Diabetic Retinopathy Risk with Type 2 Diabetes Mellitus. Journal of Personalized Medicine, 11(8), 689.
https://doi.org/10.3390/jpm11080689